Morbidity in schistosomiasis: An update

Trends in Parasitology

Volumn 17, Issue 3, 2001, Pages 117-118

  Ouma, John H ^a   Vennervald, Birgitte J ^b   Kariuki, H Curtis ^a   Butterworth, Anthony E ^c  

^a MINISTRY OF HEALTH   (Kenya)

^b DANISH BILHARZIASIS LABORATORY   (Denmark)

^c BIOMEDICAL RESEARCH AND TRAINING INSTITUTE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; MEASUREMENT; MORBIDITY; NONHUMAN; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; MALARIA; MALE; MICE; MORBIDITY; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI;

SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI;

EID: 0035014139     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(00)01877-8     Document Type: Conference Paper

References (5)

1. Morbidity in schistosomiasis: assessment, mechanisms and control
2. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity
3. The use of ultrasound in schistosomiasis
4. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-( receptor gene